TheCostsof Compliance
Author:
- 1 June 2007
- journal article
- review article
- Published by Guilford Publications in The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
- Vol. 35 (2) , 179-187
Abstract
While the many costs of noncompliance have frequently been reviewed, this article addresses some of the costs of compliance, to the detriment of patients, doctors, and the doctor-patient relationship, and to the benefit of the pharmaceutical companies. Some psychiatric history is reviewed to analyze why psychiatric practice has become so focused on making specific diagnoses and treating those with specific medicines, even as fewer than 50% of patients follow medical advice. Some evidence for specific drug treatments is presented, and the powerful effects of nonspecific therapies, usually dismissed as confounders, are explored. Lastly, an argument for collaboration rather than compliance is made, imploring physicians to tailor individual treatment to each patient, and encouraging patients to be active in their own care.Keywords
This publication has 3 references indexed in Scilit:
- The placebo: from specificity to the non-specific and backPsychological Medicine, 1993
- Congress, the FDA, and New Drug Development: Before and After 1962Perspectives in Biology and Medicine, 1989
- Treatment AdherenceThe British Journal of Psychiatry, 1976